| Salem Rehab Center | |
| 7 Loring Hills Avenue, Salem, Massachusetts 01970 | |
| (978) 741-5700 | |
| Name | Salem Rehab Center |
|---|---|
| Location | 7 Loring Hills Avenue, Salem, Massachusetts |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 123 |
| Occupancy Rate | 67.8% |
| Medicare ID (CCN) | 225644 |
| Legal Business Name | Salem Rehab Center Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1235523184 |
| Organization Name | GROSVENOR PARK HEALTH CENTER, LLC |
| Doing Business As | GROSVENOR PARK HEALTH CENTER |
| Address | 7 Loring Hills Ave, Salem, MA 01970 |
| Phone Number | 978-741-5700 |
News Archive
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
Blocking dietary sugar and its activity in tumor cells may reduce cancer risk and progression, according to researchers from the Icahn School of Medicine. The study, conducted in fruit flies and published in the journal Cell, provides insight as to why metabolism-related diseases such as diabetes or obesity are associated with certain types of cancer, including pancreatic, breast, liver, and colon cancers
Coeliac UK, the UK charity for people who need to live gluten-free, along with Innovate UK, the UK's innovation agency, have £180k available for research and are inviting applications from UK businesses and researchers.
By genomic sequencing of leukemia cells from relapsed patients at different stages, scientists have discovered key details of how acute lymphoblastic leukemia (ALL) cells mutate to survive chemotherapy. These mutations enable the cells to proliferate, causing relapse and often death.
The Global Fund to Fight AIDS, Tuberculosis and Malaria announced mid-year results for HIV and TB treatment as well as for insecticide-treated net distribution, Sify News reports.
› Verified 1 days ago
| NPI Number | 1295812691 |
| Organization Name | GROSVENOR PARK NURSING CENTER, INC |
| Address | 7 Loring Hills Ave, Salem, MA 01970 |
| Phone Number | 978-741-5700 |
News Archive
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
Blocking dietary sugar and its activity in tumor cells may reduce cancer risk and progression, according to researchers from the Icahn School of Medicine. The study, conducted in fruit flies and published in the journal Cell, provides insight as to why metabolism-related diseases such as diabetes or obesity are associated with certain types of cancer, including pancreatic, breast, liver, and colon cancers
Coeliac UK, the UK charity for people who need to live gluten-free, along with Innovate UK, the UK's innovation agency, have £180k available for research and are inviting applications from UK businesses and researchers.
By genomic sequencing of leukemia cells from relapsed patients at different stages, scientists have discovered key details of how acute lymphoblastic leukemia (ALL) cells mutate to survive chemotherapy. These mutations enable the cells to proliferate, causing relapse and often death.
The Global Fund to Fight AIDS, Tuberculosis and Malaria announced mid-year results for HIV and TB treatment as well as for insecticide-treated net distribution, Sify News reports.
› Verified 1 days ago
| NPI Number | 1689238875 |
| Organization Name | SALEM REHAB CENTER LLC |
| Address | 7 Loring Hills Ave, Salem, MA 01970 |
| Phone Number | 978-741-5700 |
News Archive
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
Blocking dietary sugar and its activity in tumor cells may reduce cancer risk and progression, according to researchers from the Icahn School of Medicine. The study, conducted in fruit flies and published in the journal Cell, provides insight as to why metabolism-related diseases such as diabetes or obesity are associated with certain types of cancer, including pancreatic, breast, liver, and colon cancers
Coeliac UK, the UK charity for people who need to live gluten-free, along with Innovate UK, the UK's innovation agency, have £180k available for research and are inviting applications from UK businesses and researchers.
By genomic sequencing of leukemia cells from relapsed patients at different stages, scientists have discovered key details of how acute lymphoblastic leukemia (ALL) cells mutate to survive chemotherapy. These mutations enable the cells to proliferate, causing relapse and often death.
The Global Fund to Fight AIDS, Tuberculosis and Malaria announced mid-year results for HIV and TB treatment as well as for insecticide-treated net distribution, Sify News reports.
› Verified 1 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
Blocking dietary sugar and its activity in tumor cells may reduce cancer risk and progression, according to researchers from the Icahn School of Medicine. The study, conducted in fruit flies and published in the journal Cell, provides insight as to why metabolism-related diseases such as diabetes or obesity are associated with certain types of cancer, including pancreatic, breast, liver, and colon cancers
Coeliac UK, the UK charity for people who need to live gluten-free, along with Innovate UK, the UK's innovation agency, have £180k available for research and are inviting applications from UK businesses and researchers.
By genomic sequencing of leukemia cells from relapsed patients at different stages, scientists have discovered key details of how acute lymphoblastic leukemia (ALL) cells mutate to survive chemotherapy. These mutations enable the cells to proliferate, causing relapse and often death.
The Global Fund to Fight AIDS, Tuberculosis and Malaria announced mid-year results for HIV and TB treatment as well as for insecticide-treated net distribution, Sify News reports.
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $19500 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 18.94 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 14.22 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 35.14 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.21 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.37 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.75 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 6.05 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 90.39 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 13.46 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 84.58 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.56 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 27.1 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 11.3 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 13.11 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 94.49 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 76.82 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 82.48 | 82.93 |
News Archive
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
Blocking dietary sugar and its activity in tumor cells may reduce cancer risk and progression, according to researchers from the Icahn School of Medicine. The study, conducted in fruit flies and published in the journal Cell, provides insight as to why metabolism-related diseases such as diabetes or obesity are associated with certain types of cancer, including pancreatic, breast, liver, and colon cancers
Coeliac UK, the UK charity for people who need to live gluten-free, along with Innovate UK, the UK's innovation agency, have £180k available for research and are inviting applications from UK businesses and researchers.
By genomic sequencing of leukemia cells from relapsed patients at different stages, scientists have discovered key details of how acute lymphoblastic leukemia (ALL) cells mutate to survive chemotherapy. These mutations enable the cells to proliferate, causing relapse and often death.
The Global Fund to Fight AIDS, Tuberculosis and Malaria announced mid-year results for HIV and TB treatment as well as for insecticide-treated net distribution, Sify News reports.
› Verified 1 days ago